---
figid: PMC9523165__fphar-13-979634-g001
figtitle: Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative
  review
organisms:
- NA
pmcid: PMC9523165
filename: fphar-13-979634-g001.jpg
figlink: /pmc/articles/PMC9523165/figure/F1/
number: F1
caption: In the PI3K/AKT/mTOR pathway, IGF-1 activates IGF-1R, and some cytokines
  activate GPER in the cell membrane. IGF-1R and GPER activate PI3K. The activated
  PI3K has a catalytic effect on the phosphorylation of PIP2 to produce PIP3. PIP3
  drives AKT. The activated AKT phosphorylates target proteins in the cytoplasmic
  fluid and cell nucleus. Finally, phosphorylation of AKT target proteins regulates
  cell survival and replication. On the other hand, PTEN (a PIP3 phosphatase) changes
  PIP3 to PIP2, suppressing the PI3K/AKT/mTOR pathway. The ERα is another receptor,
  activating PI3K through stimulating IRS1. CPT exerts its inhibitory effect on the
  PI3K/AKT/mTOR pathway by inhibiting ERα (). IGF-1, insulin-like growth factor 1;
  IGF-1R, insulin-like growth factor receptor 1; GPER, G protein-coupled receptor;
  IRS1, Insulin receptor substrate 1; PI3K, Phosphatidylinositol 3-Kinase; PIP2, Phosphatidylinositol
  (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PTEN, phosphatase
  and tensin homolog; AKT, serine/threonine protein kinase; mTORC, mammalian Target
  of Rapamycin complex; FOXO1, Forkhead box other 1; ERE, estrogen-responsive element.
papertitle: Anticancer potential of cryptotanshinone on breast cancer treatment; A
  narrative review.
reftext: Davood Dalil, et al. Front Pharmacol. 2022;13:979634.
year: '2022'
doi: 10.3389/fphar.2022.979634
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: salvia miltiorrhiza | cryptotanshinon | tanshinone C | breast cancer | molecular
  mechanism | drug combination | estrogen receptor
automl_pathway: 0.8966042
figid_alias: PMC9523165__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9523165__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9523165__fphar-13-979634-g001.html
  '@type': Dataset
  description: In the PI3K/AKT/mTOR pathway, IGF-1 activates IGF-1R, and some cytokines
    activate GPER in the cell membrane. IGF-1R and GPER activate PI3K. The activated
    PI3K has a catalytic effect on the phosphorylation of PIP2 to produce PIP3. PIP3
    drives AKT. The activated AKT phosphorylates target proteins in the cytoplasmic
    fluid and cell nucleus. Finally, phosphorylation of AKT target proteins regulates
    cell survival and replication. On the other hand, PTEN (a PIP3 phosphatase) changes
    PIP3 to PIP2, suppressing the PI3K/AKT/mTOR pathway. The ERα is another receptor,
    activating PI3K through stimulating IRS1. CPT exerts its inhibitory effect on
    the PI3K/AKT/mTOR pathway by inhibiting ERα (). IGF-1, insulin-like growth factor
    1; IGF-1R, insulin-like growth factor receptor 1; GPER, G protein-coupled receptor;
    IRS1, Insulin receptor substrate 1; PI3K, Phosphatidylinositol 3-Kinase; PIP2,
    Phosphatidylinositol (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate;
    PTEN, phosphatase and tensin homolog; AKT, serine/threonine protein kinase; mTORC,
    mammalian Target of Rapamycin complex; FOXO1, Forkhead box other 1; ERE, estrogen-responsive
    element.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHPT1
  - DHDDS
  - ESR1
  - ERAL1
  - IGF1
  - IGF1R
  - IRS1
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - GPER1
  - MTOR
  - RPTOR
  - PTEN
---
